Skip to main content
Erschienen in: Inflammation 4/2014

01.08.2014

Mycobacterium leprae Upregulates IRGM Expression in Monocytes and Monocyte-Derived Macrophages

verfasst von: Degang Yang, Jia Chen, Linglin Zhang, Zhanshan Cha, Song Han, Weiwei Shi, Ru ding, Lan Ma, Hong Xiao, Chao Shi, Zhichun Jing, Ningjing Song

Erschienen in: Inflammation | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Leprosy is caused by the infection of Mycobacterium leprae, which evokes a strong inflammatory response and leads to nerve damage. Immunity-related GTPase family M protein (IRGM) plays critical roles in controlling inflammation. The objective of the study was to investigate whether IRGM is involved in the infection of M. leprae. Levels of IRGM were assessed in M. leprae-infected CD4+ T cells, monocytes, and monocyte-derived macrophages. Data revealed that both protein and mRNA levels of IRGM were increased in monocytes after M. leprae infection. Interestingly, monocyte-derived macrophages showed more prominent IRGM expression with M. leprae infection, whereas the bacteria did not affect IRGM in CD4+ T cells. Furthermore, we assessed levels of IRGM in CD4+ T cells and monocytes from 78 leprosy patients and 40 healthy controls, and observed upregulated protein level of IRGM in the monocytes from leprosy patients. Also, IRGM expression was inversely correlated with the severity of the disease. These findings suggested a close involvement of IRGM in M. leprae infection and indicated a potential mechanism of defending M. leprae infection.
Literatur
1.
Zurück zum Zitat Bochud, P.Y., D. Sinsimer, A. Aderem, M.R. Siddiqui, P. Saunderson, S. Britton, et al. 2009. Polymorphisms in toll-like receptor 4 (TLR4) are associated with protection against leprosy. European Journal of Clinical Microbiology and Infectious Diseases 28: 1055–1065.PubMedCentralPubMedCrossRef Bochud, P.Y., D. Sinsimer, A. Aderem, M.R. Siddiqui, P. Saunderson, S. Britton, et al. 2009. Polymorphisms in toll-like receptor 4 (TLR4) are associated with protection against leprosy. European Journal of Clinical Microbiology and Infectious Diseases 28: 1055–1065.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Geluk, A. 2013. Biomarkers for leprosy: would you prefer T (cells)? Leprosy Review 84: 3–12.PubMed Geluk, A. 2013. Biomarkers for leprosy: would you prefer T (cells)? Leprosy Review 84: 3–12.PubMed
3.
Zurück zum Zitat Singh, P.K., A.V. Singh, and D.S. Chauhan. 2000. Current understanding on micro RNAs and its regulation in response to mycobacterial infections. Journal of Biomedical Science 20: 14.CrossRef Singh, P.K., A.V. Singh, and D.S. Chauhan. 2000. Current understanding on micro RNAs and its regulation in response to mycobacterial infections. Journal of Biomedical Science 20: 14.CrossRef
4.
Zurück zum Zitat Zhou, Y., L. Tang, M. Lin, S. Xu, J. Bai, and H. Song. 2013. Expression of cytotoxic T-lymphocyte antigen 4 on CD4+ and CD8+ T cells is increased in acute lung injury. DNA and Cell Biology 32: 722–726.PubMedCrossRef Zhou, Y., L. Tang, M. Lin, S. Xu, J. Bai, and H. Song. 2013. Expression of cytotoxic T-lymphocyte antigen 4 on CD4+ and CD8+ T cells is increased in acute lung injury. DNA and Cell Biology 32: 722–726.PubMedCrossRef
5.
Zurück zum Zitat Yang, D., H. Song, W. Xu, H. Long, C. Shi, Z. Jing, et al. 2011. Interleukin 4-590 T/C polymorphism and susceptibility to leprosy. Genetic Testing and Molecular Biomarkers 15: 877–881.PubMedCrossRef Yang, D., H. Song, W. Xu, H. Long, C. Shi, Z. Jing, et al. 2011. Interleukin 4-590 T/C polymorphism and susceptibility to leprosy. Genetic Testing and Molecular Biomarkers 15: 877–881.PubMedCrossRef
6.
7.
Zurück zum Zitat Kim, B.H., A.R. Shenoy, P. Kumar, C.J. Bradfield, and J.D. MacMicking. 2012. IFN-inducible GTPases in host cell defense. Cell Host & Microbe 12: 432–444.CrossRef Kim, B.H., A.R. Shenoy, P. Kumar, C.J. Bradfield, and J.D. MacMicking. 2012. IFN-inducible GTPases in host cell defense. Cell Host & Microbe 12: 432–444.CrossRef
8.
Zurück zum Zitat Grégoire, I.P., C. Rabourdin-Combe, and M. Faure. 2012. Autophagy and RNA virus interactomes reveal IRGM as a common target. Autophagy 8: 1136–1137.PubMedCentralPubMedCrossRef Grégoire, I.P., C. Rabourdin-Combe, and M. Faure. 2012. Autophagy and RNA virus interactomes reveal IRGM as a common target. Autophagy 8: 1136–1137.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat MacMicking, J.D., G.A. Taylor, and J.D. McKinney. 2003. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302: 654–659.PubMedCrossRef MacMicking, J.D., G.A. Taylor, and J.D. McKinney. 2003. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302: 654–659.PubMedCrossRef
10.
Zurück zum Zitat Ling, Y.M., M.H. Shaw, C. Ayala, I. Coppens, G.A. Taylor, D.J. Ferguson, et al. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. The Journal of Experimental Medicine 203: 2063–2071.PubMedCentralPubMedCrossRef Ling, Y.M., M.H. Shaw, C. Ayala, I. Coppens, G.A. Taylor, D.J. Ferguson, et al. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. The Journal of Experimental Medicine 203: 2063–2071.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Duerr, R.H., K.D. Taylor, S.R. Brant, J.D. Rioux, M.S. Silverberg, M.J. Daly, et al. 2006. Science 314: 1461–1463.PubMedCrossRef Duerr, R.H., K.D. Taylor, S.R. Brant, J.D. Rioux, M.S. Silverberg, M.J. Daly, et al. 2006. Science 314: 1461–1463.PubMedCrossRef
12.
Zurück zum Zitat Harris, J., J.C. Hope, and E.C. Lavelle. 2009. Autophagy and the immune response to TB. Transboundary Emerging Diseases 56: 248–254.PubMedCrossRef Harris, J., J.C. Hope, and E.C. Lavelle. 2009. Autophagy and the immune response to TB. Transboundary Emerging Diseases 56: 248–254.PubMedCrossRef
13.
Zurück zum Zitat Roberts, R.L., J.E. Hollis-Moffatt, R.B. Gearry, M.A. Kennedy, M.L. Barclay, and T.R. Merriman. 2008. Confirmation of association of IRGM and NCF4 with ileal Crohn’s disease in a population-based cohort. Genes and Immunity 9: 561–565.PubMedCrossRef Roberts, R.L., J.E. Hollis-Moffatt, R.B. Gearry, M.A. Kennedy, M.L. Barclay, and T.R. Merriman. 2008. Confirmation of association of IRGM and NCF4 with ileal Crohn’s disease in a population-based cohort. Genes and Immunity 9: 561–565.PubMedCrossRef
14.
Zurück zum Zitat Song, H., S. Ma, Z. Cha, L. Chen, D. Tong, L. Ma, et al. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation 36: 793–799. Song, H., S. Ma, Z. Cha, L. Chen, D. Tong, L. Ma, et al. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation 36: 793–799.
15.
Zurück zum Zitat Lahiri, R., B. Randhawa, and J. Krahenbuhl. 2005. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. Journal of Medical Microbiology 54: 235–242.PubMedCrossRef Lahiri, R., B. Randhawa, and J. Krahenbuhl. 2005. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. Journal of Medical Microbiology 54: 235–242.PubMedCrossRef
16.
Zurück zum Zitat Cha, Z., Y. Zang, H. Guo, J.R. Rechlic, L.M. Olasnova, H. Gu, et al. 2013. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. Tumour Biology 34:3579–3585. Cha, Z., Y. Zang, H. Guo, J.R. Rechlic, L.M. Olasnova, H. Gu, et al. 2013. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. Tumour Biology 34:3579–3585.
17.
Zurück zum Zitat Murray, R.A., M.R. Siddiqui, M. Mendillo, J. Krahenbuhl, and G. Kaplan. 2007. Mycobacterium leprae inhibits dendritic cell activation and maturation. Journal of Immunology 178: 338–344.CrossRef Murray, R.A., M.R. Siddiqui, M. Mendillo, J. Krahenbuhl, and G. Kaplan. 2007. Mycobacterium leprae inhibits dendritic cell activation and maturation. Journal of Immunology 178: 338–344.CrossRef
18.
Zurück zum Zitat Yang, D., J. Chen, C. Shi, Z. Jing, and N. Song. 2013. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. doi:10.1007/s10753-013-9773-1. Yang, D., J. Chen, C. Shi, Z. Jing, and N. Song. 2013. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. doi:10.​1007/​s10753-013-9773-1.
19.
Zurück zum Zitat Song, H., E.E. Nakayama, and T. Shioda. 2006. Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages. AIDS 20: 937–939.PubMedCrossRef Song, H., E.E. Nakayama, and T. Shioda. 2006. Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages. AIDS 20: 937–939.PubMedCrossRef
Metadaten
Titel
Mycobacterium leprae Upregulates IRGM Expression in Monocytes and Monocyte-Derived Macrophages
verfasst von
Degang Yang
Jia Chen
Linglin Zhang
Zhanshan Cha
Song Han
Weiwei Shi
Ru ding
Lan Ma
Hong Xiao
Chao Shi
Zhichun Jing
Ningjing Song
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9825-1

Weitere Artikel der Ausgabe 4/2014

Inflammation 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.